IL115020A0 - Methods for inhibiting neuronal damage - Google Patents

Methods for inhibiting neuronal damage

Info

Publication number
IL115020A0
IL115020A0 IL11502095A IL11502095A IL115020A0 IL 115020 A0 IL115020 A0 IL 115020A0 IL 11502095 A IL11502095 A IL 11502095A IL 11502095 A IL11502095 A IL 11502095A IL 115020 A0 IL115020 A0 IL 115020A0
Authority
IL
Israel
Prior art keywords
methods
neuronal damage
inhibiting neuronal
inhibiting
damage
Prior art date
Application number
IL11502095A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL115020A0 publication Critical patent/IL115020A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11502095A 1994-08-22 1995-08-21 Methods for inhibiting neuronal damage IL115020A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/293,852 US5512296A (en) 1994-08-22 1994-08-22 Methods for inhibiting neuronal damage

Publications (1)

Publication Number Publication Date
IL115020A0 true IL115020A0 (en) 1995-12-08

Family

ID=23130862

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11502095A IL115020A0 (en) 1994-08-22 1995-08-21 Methods for inhibiting neuronal damage

Country Status (10)

Country Link
US (1) US5512296A (fr)
EP (1) EP0769937A4 (fr)
JP (1) JPH10504577A (fr)
AU (1) AU3369695A (fr)
CA (1) CA2198015A1 (fr)
IL (1) IL115020A0 (fr)
MX (1) MX9701333A (fr)
TW (1) TW296344B (fr)
WO (1) WO1996005811A1 (fr)
ZA (1) ZA956992B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417198B1 (en) 1993-12-21 2002-07-09 Eli Lilly And Company Methods of inhibiting CNS problems in post-menopausal women
ZA982877B (en) * 1997-04-09 1999-10-04 Lilly Co Eli Treatment of central nervous system disorders with selective estrogen receptor modulators.
US5990129A (en) * 1997-09-23 1999-11-23 Eli Lilly And Company Methods for regulating trkA expression
JP2002518329A (ja) 1998-06-16 2002-06-25 イーライ・リリー・アンド・カンパニー アセチルコリンレベルを増加させる方法
US6288108B1 (en) 1998-06-16 2001-09-11 Eli Lilly And Company Methods for increasing levels of acetylcholine
AU777770C (en) 1999-05-04 2005-11-10 Strakan International Limited Androgen glycosides and androgenic activity thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US6417198B1 (en) * 1993-12-21 2002-07-09 Eli Lilly And Company Methods of inhibiting CNS problems in post-menopausal women
US5534526A (en) * 1993-12-21 1996-07-09 Eli Lilly And Company Methods for inhibiting vasomotor symptoms and attending psychological disturbances surrounding post-menopausal syndrome

Also Published As

Publication number Publication date
ZA956992B (en) 1997-02-21
CA2198015A1 (fr) 1996-02-29
AU3369695A (en) 1996-03-14
MX9701333A (es) 1997-05-31
WO1996005811A1 (fr) 1996-02-29
EP0769937A4 (fr) 1999-08-11
EP0769937A1 (fr) 1997-05-02
JPH10504577A (ja) 1998-05-06
TW296344B (fr) 1997-01-21
US5512296A (en) 1996-04-30

Similar Documents

Publication Publication Date Title
IL114188A0 (en) Method for idal-in access security
GB9521447D0 (en) Method
IL130452A0 (en) Method for protecting plants
GR3024098T3 (en) Apparatus for electro-fishing
GB2289946B (en) Method
GB2302308B (en) Anti counterfeit apparatus
HU9503783D0 (en) Squvalen syntetase inhibitors
GB9417135D0 (en) Method
IL115020A0 (en) Methods for inhibiting neuronal damage
GB9403744D0 (en) Line protecting apparatus
DE69523450D1 (en) Inhibitor
GB9424723D0 (en) Method
GB9414902D0 (en) Methods
GB9401566D0 (en) Method
GB9419941D0 (en) Putting practice aid
KR970006538Y1 (en) Device for preventing oil-leakage
HU9402500D0 (en) Method for protecting from sliding
IL111270A0 (en) Device for preventing drowsing
KR970005479Y1 (en) Device for protecting railings
KR0110036Y1 (en) Sub-tool for lench
KR0112033Y1 (en) Airating device for hydrophonics
KR0112034Y1 (en) Airating device for hydrophonics
GB9405135D0 (en) Improved tarnish removal system
GB9406592D0 (en) Methods
GB9418166D0 (en) Methods